Table 3.
Multivariate conditional logistic models on prevalence of health conditions (controlling for alcohol use disorders and tobacco use) odds ratios (95% confidence interval)
| Cannabis Use Disorder (CUD)-Documented vs Matched Controls | Cannabis Use (no disorder) (CU)-Documented vs Matched Controls | Cannabis Use Disorder (CUD)-Documented vs Cannabis Use (no disorder) (CU) -Documented | |
|---|---|---|---|
| General Medical Conditions | |||
| Cancer |
2.00 (1.43–2.80)** |
1.65 (1.44–1.88)** |
1.21 (0.85–1.73) |
| Diabetes Mellitus |
1.95 (1.26–3.02) |
1.23 (1.01–1.50) |
1.58 (0.99–2.53) |
| Nervous System Disease |
2.67 (2.06–3.47)** |
2.01 (1.81–2.24)** |
1.33 (1.01–1.75) |
| Sleep Disorders |
3.70 (2.69–5.08)** |
2.38 (2.07–2.74)** |
1.55 (1.11–2.17) |
| Circulatory System Disease |
2.04 (1.54–2.69)** |
1.69 (1.50–1.90)** |
1.20 (0.90–1.62) |
| Respiratory Disease |
1.58 (1.24–2.00)* |
1.65 (1.49–1.83)** |
0.95 (0.74–1.23) |
| Digestive System Disease |
2.08 (1.62–2.67)** |
2.03 (1.82–2.25)** |
1.03 (0.79–1.34) |
| Liver Disease |
1.86 (1.20–2.90)* |
1.68 (1.37–2.06)** |
1.11 (0.69–1.78) |
| Musculoskeletal Disease |
1.76 (1.36–2.26)** |
1.67 (1.51–1.85)** |
1.05 (0.80–1.37) |
| HIV/AIDS |
7.88 (2.58–24.08)* |
1.18 (0.69–2.00) |
6.70 (2.10–21.39)** |
| Sexually Transmitted Disease Other Than HIV/AIDS |
3.39 (1.81–6.36)** |
2.28 (1.68–3.08)** |
1.49 (0.75–2.94) |
| Mental Health Disorders |
6.99 (5.03–9.70)** |
2.81 (2.51–3.15)** |
2.48 (1.76–3.51)** |
| Substance Use Disorder (other than alcohol, cannabis, tobacco) |
21.44 (9.43–48.73)** |
3.64 (2.53–5.25)** |
5.88 (2.43–14.22)** |
| Conditions Known To Be Associated With Cannabis | |||
| Respiratory Disease |
1.58 (1.24–2.00)* |
1.69 (1.05–2.73) |
0.95 (0.74–1.23) |
| COPD |
1.67 (1.23–2.27) |
1.49 (1.30–1.71)* |
1.12 (0.81–1.55) |
| Chronic Obstructive Pulmonary Disease |
2.51 (1.47–4.30)* |
1.57 (1.26–1.95)** |
1.61 (0.90–2.85) |
| Cancer |
2.00 (1.43–2.80)** |
1.65 (1.44–1.88)* |
1.21 (0.85–1.73) |
| Ischemic Heart Disease |
2.51 (1.47–4.30)* |
1.57 (1.26–1.95)** |
1.61 (0.90–2.85) |
| Obstructive Sleep Apnea |
2.11 (1.27–3.50)* |
2.07 (1.64–2.62)** |
1.02 (0.59–1.75) |
| Multiple Sclerosis |
6.09 (0.64–57.44) |
3.14 (1.38–7.12)* |
1.94 (0.20–18.81) |
| HIV-AIDS |
7.88 (2.58–24.08)* |
2.28 (1.68–3.08)** |
6.70 (2.10–21.39)* |
| Tourette Syndrome |
0 (0.00–1.00) |
2.00 (0.18–22.06) |
0 (0.00–1.00) |
| Testicular Cancer |
2.11 (0.25–18.05) |
0.70 (0.27–1.86) |
3.00 (0.30–29.75) |
| Chronic Pain |
1.85 (1.44–2.38)** |
1.74 (1.57–1.93)** |
1.06 (0.81–1.38) |
| Schizophrenia/Psychotic Disorder |
5.98 (2.23–16.03)* |
1.69 (1.05–2.73) |
3.53 (1.18–10.53) |
| Depression |
7.01 (4.79–10.27)** |
2.46 (2.15–2.81)** |
2.85 (1.90–4.26)** |
| Anxiety |
5.99 (4.37–8.21)** |
2.74 (2.43–3.08)** |
2.19 (1.57–3.05)** |
| Bipolar Disorder |
6.49 (2.90–14.52)** |
2.54 (1.84–3.51)** |
2.56 (1.07–6.09) |
| Social Anxiety Disorder |
13.03 (2.18–77.94)* |
1.64 (0.85–3.17) |
7.93 (1.24–50.59) |
| Post-Traumatic Stress Disorder |
7.74 (2.66–22.51)* |
3.41 (1.99–5.83)** |
2.27 (0.73–7.13) |
| Substance Use Disorder (other than alcohol, cannabis, tobacco) |
21.44 (9.43–48.73)** |
3.64 (2.53–5.25)** |
5.88 (2.43–14.22)* |
*P = < .01 **P = < .001